Skip Navigation

A Pilot Study of Tazemetostat and Pembrolizumab MK-3475 in Advanced Urothelial Carcinoma

Brief Summary

Type:
Bladder

Study Type:
Treatment

Phase:
Feasibility/Pilot

ClinicalTrials.gov Identifier:
NCT03854474

Study #:
STUDY00146152

Start Date:
Mar 01, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03854474

View Complete Trial Details & Eligibility at ClinicalTrials.gov